about
Icon is a global contract research organization that provides outsourced clinical development services to pharmaceutical and biotechnology firms. Icon supports clients across late-stage clinical trials through the regulatory approval process and post...
Read More
169.55
5.44
(3.31%)
1.0M
XNAS Volume
XNAS 21 Sep, 2026 5:30 PM (EDT)
Medium Financial Strength
Mid Valuation
Technically Bullish
Turnaround Potential
These stocks have average financials and valuation, but strong momentum indicating buying interest
View Similar
Embed DVM
Icon PLC Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..